A Study to Explore the Efficacy of Alprostadil Liposomes Injection in the Prevention of CI-AKI

Clinical trial NCT05475717 · TERMINATED

Trial details

NCT number: NCT05475717
Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Contrast-induced Acute Kidney Injury

Start date: 2022-10-20
Primary completion: 2023-12-04
Enrollment: 132

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.